Cytokine Storm in COVID-19: "When You Come Out of the Storm, You Won't Be the Same Person Who Walked in"
- PMID: 32983172
- PMCID: PMC7492381
- DOI: 10.3389/fimmu.2020.02132
Cytokine Storm in COVID-19: "When You Come Out of the Storm, You Won't Be the Same Person Who Walked in"
Abstract
In December 2019, a novel coronavirus, COVID-19, was discovered to be the causal agent of a severe respiratory infection named SARS-CoV-2, and it has since been recognized worldwide as a pandemic. There are still numerous doubts concerning its pathogenesis and particularly the underlying causes of the various clinical courses, ranging from severe manifestations to asymptomatic forms, including acute respiratory distress syndrome. The major factor responsible for acute respiratory distress syndrome is the so-called "cytokine storm," which is an aberrant response from the host immune system that induces an exaggerated release of proinflammatory cytokines/chemokines. In this review, we will discuss the role of cytokine storm in COVID-19 and potential treatments with which counteract this aberrant response, which may be valuable in the clinical translation.
Keywords: SARS-CoV2; acute respiratory distress; coronavirus; cytokines; inflammation; severity.
Copyright © 2020 Castelli, Cimini and Ferri.
Figures
Similar articles
-
Weathering the Cytokine Storm in COVID-19: Therapeutic Implications.Cardiorenal Med. 2020;10(5):277-287. doi: 10.1159/000509483. Epub 2020 Jun 29. Cardiorenal Med. 2020. PMID: 32599589 Free PMC article. Review.
-
The COVID-19 Cytokine Storm; What We Know So Far.Front Immunol. 2020 Jun 16;11:1446. doi: 10.3389/fimmu.2020.01446. eCollection 2020. Front Immunol. 2020. PMID: 32612617 Free PMC article. Review.
-
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.Cytokine Growth Factor Rev. 2020 Jun;53:25-32. doi: 10.1016/j.cytogfr.2020.05.003. Epub 2020 May 11. Cytokine Growth Factor Rev. 2020. PMID: 32446778 Free PMC article. Review.
-
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies.Front Immunol. 2020 Jul 10;11:1708. doi: 10.3389/fimmu.2020.01708. eCollection 2020. Front Immunol. 2020. PMID: 32754163 Free PMC article. Review.
-
Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.Life Sci. 2020 Sep 15;257:118102. doi: 10.1016/j.lfs.2020.118102. Epub 2020 Jul 18. Life Sci. 2020. PMID: 32687918 Free PMC article. Review.
Cited by
-
Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm.Life (Basel). 2022 Mar 25;12(4):478. doi: 10.3390/life12040478. Life (Basel). 2022. PMID: 35454970 Free PMC article. Review.
-
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein.Dis Markers. 2022 Feb 28;2022:3528312. doi: 10.1155/2022/3528312. eCollection 2022. Dis Markers. 2022. PMID: 35242241 Free PMC article.
-
SARS-CoV-2 infection in patients with serious mental illness and possible benefits of prophylaxis with Memantine and Amantadine.Rom J Morphol Embryol. 2020 Oct-Dec;61(4):1007-1022. doi: 10.47162/RJME.61.4.03. Rom J Morphol Embryol. 2020. PMID: 34171050 Free PMC article. Review.
-
The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications.Viruses. 2021 Jul 12;13(7):1346. doi: 10.3390/v13071346. Viruses. 2021. PMID: 34372552 Free PMC article. Review.
-
Ischemic modified albumin and thiol levels in Coronavirus disease 19: a systematic review and meta-analysis.Diagn Progn Res. 2025 Jun 23;9(1):13. doi: 10.1186/s41512-025-00196-6. Diagn Progn Res. 2025. PMID: 40551274 Free PMC article. Review.
References
-
- WHO WHO Coronavirus Disease (COVID-19) Dashboard. Available online at: https://covid19.who.int/ (accessed July 31, 2020).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous